In this Section |
172989 Cost-effectiveness of a WISEWOMAN behavioral weight loss intervention for low-income women: The Weight-Wise ProgramTuesday, October 28, 2008: 5:15 PM
To assess the cost-effectiveness of an evidence-based weight-loss intervention adapted for low-income midlife women participating in the Centers for Disease Control and Prevention (CDC) WISEWOMAN program. A randomized controlled trial testing a 16-week evidence-based intervention with women enrolled from one community health center.143 women (40 – 64 years old, mean BMI 35.1) randomized to one of two arms – special intervention (n=72) and a wait-listed control group (n=71). Effectiveness measures included changes in weight, systolic and diastolic blood pressure, total cholesterol, and HDL cholesterol. Cost-effectiveness measures calculated Life Years Gained (LYG) from a reduction in coronary heart disease risk (CHD) based on a 10-year CHD risk algorithm. In addition, LYG were calculated from changes in weight, based on excess Years Life Lost (YLL) algorithm. The cost-effectiveness analysis assessed the incremental cost-effectiveness of providing the special intervention and was calculated as: [Cost of intervention] / [D in LYG from a reduction in CHD or Obesity Risk between intervention and control participants].Weight-Wise intervention participants had statistically significant decreases in weight (kg) [-4.4 95% CI (-5.6, - 3.2)] and in systolic blood pressure [-6.2 mm Hg, 95% CI (-10.6, -1.7)] compared to control participants. Total intervention cost of conducting Weight Wise was $13,699 and cost per participant in the intervention group, $190. The incremental cost per Life Year Gained (discounted) from a decrease in obesity was $1,462 and $4,750 from a decrease in CHD risk.
Our results suggest Weight-Wise intervention may be a cost-effective approach to improving the health of low-income women.
Learning Objectives: Keywords: Weight Management, Low-Income
Presenting author's disclosure statement:
Qualified on the content I am responsible for because: I have collected all data and have been author on development I agree to comply with the American Public Health Association Conflict of Interest and Commercial Support Guidelines, and to disclose to the participants any off-label or experimental uses of a commercial product or service discussed in my presentation.
See more of: Physical Activity and Obesity Prevention Strategies Among Women
See more of: Public Health Education and Health Promotion |